
Max Healthcare Q1 FY25 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 3
Margin
Category 4
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 3- Network gross revenue grew 18% YoY and 7% QoQ in Q1 FY25, indicating continued sales growth.
- Occupancy increased to 77%, with occupied bed days growing ~5% YoY; volume growth expected with capacity expansions.
- Brownfield expansions (e.g., Lucknow, Nagpur, Shalimar Bagh) will drive volume growth as new beds fill up, with up to 34-35% volume increases noted in expansions.
- ARPOB growth is expected around 7-10% annually, driven by tariff revisions and higher-end procedures.
- New hospitals currently have lower ARPOB (~Rs. 45,000) than existing hospitals (~Rs. 80,000), but expected to rise to Rs. 60,000-65,000 within a year.
- International patient business is growing faster than other segments, increasing its revenue share.
- Expansion plans will increase capacity by several hundred beds over next 1-2 years, supporting volume and revenue growth.
- Overall, steady-state growth rates in existing hospitals’ inpatient volumes are expected in high single digits.
See what Max Healthcare management said on margin guidance — free account, 30 seconds.
Fundraise plans
- There is no mention of any current or planned fundraising through debt or equity in the transcript.
- All the ongoing and planned expansions are being funded through internal accruals.
- The company pursues asset-light models such as built-to-suit with long-term leases to limit upfront capital expenditure.
- For example, the Mohali hospital is a 50-year lease model where the developer incurs the project cost except for medical equipment and fit-outs provided by the company.
- No specific plans for external fundraising were indicated during the call or in the disclosed expansion updates.
See what Max Healthcare management said on order book — free account, 30 seconds.
Capex plans
Yes- Mohali Hospital (250 beds): Built-to-suit 2.75 lakh sq.ft. facility on 50-year lease; developer funds land/building; company invests in medical equipment and fit-outs. Commission expected by FY28.
- Lucknow Hospital: Refurbishing existing 250-bed facility; adding 140 beds by end FY24; new 450-bed tower with EC approval, expected completion within 24 months.
- Nagpur Hospital: Adding 25 beds via reconfiguration by Q3 FY25; EC approval filed for 115 additional beds, expected completion in 24 months.
- Nanavati Hospital (Phase I): New 241-bed structure expected to be completed by FY25 end; project on schedule.
- Max Smart (Saket Complex): 375-bed steel structure building fast-tracked; completion expected by Q1 FY26.
- Expansion mostly funded through internal accruals, following an asset-light strategy minimizing development risks.
Track Max Healthcare — get its next earnings analysis in your feed
How does Max Healthcare rank vs peers in Healthcare Services?
Pro featureHow does Max Healthcare rank in Healthcare Services?
Compare Max Healthcare against every Healthcare Services company (Q1 FY25) on revenue, margins and earnings-call signals.
Continue your research
What Max Healthcare's management said in earlier quarters
Others in Healthcare Services this season
- Chandan Healthca (Q2 FY27)
Q2 FY27 operating income: ₹57.94 Cr, up 45.04% YoY from ₹39.95 Cr (Page 8) . Key investor presentation takeaways from Chandan Healthcare Ltd's Q2 FY27 investor
- Invicta Diagnostic (Q2 FY27)
Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2
- Unihealth Hosp (Q2 FY27)
1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r
- Sangani Hospital (Q2 FY27)
1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.